The global mRNA quality monitoring market size was valued at USD 1.28 billion in 2024 and is predicted to hit around USD 2.5 ...

Moderna is seeking to enhance some of its drugs with Nanexa’s technology as the biologics sector moves to less frequent ...

The mRNA synthesis and manufacturing market's potential lies in the increasing demand for mRNA therapeutics and vaccines, driven by COVID-19 successes. Opportunities include mRNA custom synthesis and ...

The U.S. is in "big danger" of falling behind in vaccine technology research as government funding declines and vaccine ...

KAIST researchers have developed a method that attaches DNA fragments to mRNA to slow the onset of protein production, ...

Specifically, the team tested whether mRNA technology could be used to protect against the damage inflicted by the venom of ...

Moderna (NASDAQ: MRNA) extended gains for the seventh consecutive trading session, with the stock closing 2.14% higher at $29 ...

Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause ...

The U.S. government is turning its back on a medical breakthrough that has saved millions of lives, halting $500 million in ...

Commentary: Health and Human Services justified its decision by citing public mistrust in vaccines based on mRNA technology, ...

A new preclinical study shows that mRNA delivered through lipid nanoparticles can trigger local antibody production in muscle ...